ZA842067B - (1h-tetrazol-5-yl)tetrazolo-(1,5-a)-quinolines and related compounds - Google Patents

(1h-tetrazol-5-yl)tetrazolo-(1,5-a)-quinolines and related compounds

Info

Publication number
ZA842067B
ZA842067B ZA842067A ZA842067A ZA842067B ZA 842067 B ZA842067 B ZA 842067B ZA 842067 A ZA842067 A ZA 842067A ZA 842067 A ZA842067 A ZA 842067A ZA 842067 B ZA842067 B ZA 842067B
Authority
ZA
South Africa
Prior art keywords
tetrazolo
quinolines
tetrazol
related compounds
compounds
Prior art date
Application number
ZA842067A
Other languages
English (en)
Inventor
Terry L Wright
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA842067B publication Critical patent/ZA842067B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
ZA842067A 1983-03-25 1984-03-20 (1h-tetrazol-5-yl)tetrazolo-(1,5-a)-quinolines and related compounds ZA842067B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/478,964 US4496569A (en) 1983-03-25 1983-03-25 Antiallergic (1H-tetrazol-5-yl)tetrazolo[1,5-a]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
ZA842067B true ZA842067B (en) 1984-10-31

Family

ID=23902115

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA842067A ZA842067B (en) 1983-03-25 1984-03-20 (1h-tetrazol-5-yl)tetrazolo-(1,5-a)-quinolines and related compounds

Country Status (19)

Country Link
US (1) US4496569A (el)
EP (1) EP0120484B1 (el)
JP (1) JPS59176287A (el)
KR (1) KR900003649B1 (el)
AT (1) ATE26717T1 (el)
AU (1) AU558762B2 (el)
CA (1) CA1252100A (el)
DE (1) DE3463271D1 (el)
DK (1) DK165694C (el)
ES (1) ES8601970A1 (el)
GR (1) GR81463B (el)
IE (1) IE57072B1 (el)
IL (1) IL71318A (el)
MX (1) MX9203341A (el)
NO (1) NO161067C (el)
NZ (1) NZ207582A (el)
PH (1) PH20353A (el)
PT (1) PT78288B (el)
ZA (1) ZA842067B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014171A1 (de) * 1990-05-03 1991-11-07 Basf Ag Cyanochinolinverbindungen
DK0751945T3 (da) * 1994-03-25 1999-04-12 Merrell Pharma Inc Fremgangsmåde til fremstilling af (1H-tetrazol-5-yl)tetrazolo[1,5-A]quinoliner og -naphthyridiner
JP3674407B2 (ja) 1999-09-21 2005-07-20 ヤマハ株式会社 演奏データ編集装置、方法及び記録媒体
EP1668009A1 (en) * 2003-09-26 2006-06-14 Rigel Pharmaceuticals, Inc. Hcv inhibitors and methods of using them
WO2005121138A2 (en) * 2004-06-03 2005-12-22 Rigel Pharmaceuticals, Inc. Heterotricyclic compounds for use as hcv inhibitors
KR101101950B1 (ko) * 2011-11-04 2012-01-02 이동진 왕복 페달식 자전거

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764681A (en) * 1970-07-08 1973-10-09 Lilly Co Eli Certain tetrazolo-(1,5-a) quinoline compounds as fungus control agents
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds

Also Published As

Publication number Publication date
KR840008156A (ko) 1984-12-13
PH20353A (en) 1986-12-04
AU2595384A (en) 1984-09-27
MX9203341A (es) 1992-08-01
US4496569A (en) 1985-01-29
AU558762B2 (en) 1987-02-05
NZ207582A (en) 1986-10-08
GR81463B (el) 1984-12-11
NO841156L (no) 1984-09-26
DE3463271D1 (en) 1987-05-27
ES530876A0 (es) 1985-11-01
CA1252100A (en) 1989-04-04
JPH0415791B2 (el) 1992-03-19
NO161067B (no) 1989-03-20
DK165584A (da) 1984-09-26
EP0120484B1 (en) 1987-04-22
NO161067C (no) 1989-06-28
PT78288B (en) 1986-04-22
IE840719L (en) 1984-09-25
ES8601970A1 (es) 1985-11-01
DK165694B (da) 1993-01-04
KR900003649B1 (ko) 1990-05-28
IL71318A (en) 1986-11-30
IE57072B1 (en) 1992-04-22
JPS59176287A (ja) 1984-10-05
DK165584D0 (da) 1984-03-23
ATE26717T1 (de) 1987-05-15
DK165694C (da) 1993-06-07
IL71318A0 (en) 1984-06-29
PT78288A (en) 1984-04-01
EP0120484A1 (en) 1984-10-03

Similar Documents

Publication Publication Date Title
AU2587384A (en) Benzimidazole or imidazo (4,5-6) pyrioine derivatives
AU8188987A (en) Improved metal complex-containing pharmaceutical agents
PT78289A (en) (1h-tetrazol-5-yl)2(1h)-quinolines and related compounds
ZA841603B (en) Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings
DE3463271D1 (en) (1h-tetrazol-5-yl)tetrazolo (1,5-a)-quinolines and related compounds
JPS5790160A (en) Multi-purpose blood diluting agent for stabilization
IE831145L (en) Pyridine derivatives
DE3469295D1 (en) Derivatives of pyridine, pyrazine and pyrimidine and their use as fungicidal agents
PH21465A (en) 5-substituted-6-amino pyrimidine derivatives, composition and uses as cardiotonic agents for increasing cardiac contractility
ATE41003T1 (de) Tetrazolothienopyridine.
EP0274524A4 (en) PYRIDONE-PYRIDYL-IMIDAZOLYL AND TRIAZOLYL COMPOUNDS AND USES THEREOF AS CARDIOTONIC AGENTS.
ZA842335B (en) New five-membered nitrogen-containing heterocyclic compounds,processes for their preparation and their use as pets-combating agents
DE3478437D1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
DE3475193D1 (en) Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings
GB2150558B (en) 6-amino-9-hydroxy-3-azabicyclo(3.3.1)nonane derivatives
DK33684D0 (da) Pyrazino (2',3'-3,4)pyrido(1,2-a)-indol-derivater
ES8505357A1 (es) Un procedimiento para la preparacion de derivados de carboxi-tiazolo (3,2-a) pirimidina nuevos
DE3576076D1 (de) (tetrazolyl)thienopyridone.
AU589745B2 (en) 2', 3', 4', 10'-tetrahydro-10'-substituted-10'-hydroxy-spiro ((cycloalkane or heterocyclic)-pyrimido(1,2a)indoles
ES8602681A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzazepina